Skip to main content
Signal8
Launch Terminal

Exousia Bio, Inc. (LMMY)

Exousia Bio, Inc. is a biotechnology company that designs, develops, and manufactures mammalian- and plant-derived exosomes using proprietary technologies for nucleic acid loading and targeted delivery to tissues and cells. The company's platform enables the custom production of exosomes with enhanced genetic functionality that can selectively target specific cells to address diseases. The company was formerly known as LAMY and changed its name to Exousia Bio, Inc. in January 2026.

Sector: Services-Educational Services

Industry: Education & Training Services

L A M Y logo

L A M Y

OTC:LMMYConsumer Defensive
-15.38%$0.0121
Mkt Cap$635K
Float47.48M
O/S52.5M
Inst Own-
Dilution
L A M Y logoOTC:LMMY$0.0121-15.38%
FormDescription
15-12G
TERMINATION OF REGISTRATION STMT
3
10-Q
QUARTERLY REPORT FOR FEB 2026
5
NT 10-Q
EXTENSION
10-Q
FORM 10-Q FOR NOV 2025
NT 10-Q
EXTENSION
8-K
1.01,2.01,3.02,5.01,5.02,9.01
10-Q
Quarterly Report
10-K
ANNUAL REPORT
NT 10-Q
EXTENSION
NT 10-K
EXTENSION
10-Q
Quarterly Report
NT 10-Q
EXTENSION
10-Q
FORM 10-Q FOR NOV 2024
8-K
5.01,5.02
10-Q
QUARTERLY REPORT
10-K
ANNUAL REPORT
NT 10-K
FORM 12B-25
8-K
4.01,9.01
10-Q
FORM 10-Q FOR 2-29-24
10-Q
FORM 10-Q FOR PERIOD ENDING 11/30/23
10-K/A
AMENDMENT #1 TO FORM 10-K
10-Q
QUARTERLY REPORT
8-A12G
SEC Filing
10-K
Annual Report
10-Q
Quarterly Report

1-25 of 50